Majority of Patients Experience Disease Stabilization With Mipsagargin in Refractory HCC Trial

Press/Media: Press / Media

PeriodApr 24 2017

Media coverage

1

Media coverage

  • TitleMajority of Patients Experience Disease Stabilization With Mipsagargin in Refractory HCC Trial
    Media name/outletTargeted Oncology
    CountryUnited States
    Date4/24/17
    PersonsDevalingam Mahalingam